Products

Itch Relief Agent

    • Product Name: Itch Relief Agent
    • Alias: anti_itch
    • Einecs: 211-076-1
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    475021

    Name Itch Relief Agent
    Type Topical
    Form Cream
    Active Ingredient Hydrocortisone
    Concentration 1%
    Intended Use Temporary relief of itching
    Application Area External skin
    Age Restriction For ages 2 and up
    Fragrance Free Yes
    Storage Temperature Store at 20-25°C

    As an accredited Itch Relief Agent factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Itch Relief Agent comes in a sealed, 100 mL amber glass bottle with a child-resistant cap and clear, bilingual safety labeling.
    Shipping The shipping of **Itch Relief Agent** requires secure, compliant packaging to prevent leaks and contamination. It must be transported in clearly labeled, sealed containers, accompanied by a Safety Data Sheet (SDS). Ship via standard ground or air freight, following all relevant chemical handling and regulatory guidelines. Store away from extreme temperatures.
    Storage The chemical `Itch Relief Agent` should be stored in a tightly closed container, in a cool, dry, and well-ventilated area away from direct sunlight and incompatible substances. Keep it out of reach of unauthorized personnel. Store at room temperature and avoid excessive heat or moisture. Ensure appropriate labeling and follow all safety regulations for safe chemical storage and handling.
    Application of Itch Relief Agent

    Applications of Itch Relief Agent in Industrial Manufacturing

    Our itch relief agent supports specialized downstream industrial processes where irritation management is crucial. Recognized for its efficacy and regulatory acceptance, the material integrates seamlessly within advanced formulations. The following sections introduce key industrial markets utilizing this raw material, focusing on application-specific compliance, dosage, processing, and end-use.

    1. Topical Pharmaceutical Cream & Ointment Manufacturing

    Pharmaceutical companies include this itch control ingredient in prescription and over-the-counter topical products targeting dermatitis, eczema, and allergic reactions. Formulators blend it with appropriate excipients at the emulsification or cooling stage, ensuring consistent dispersion and targeted local activity. Process batches undergo strict in-process controls under validated GMP environments to meet regulatory standards. The final products are subject to full QC analysis including assay, microbial limits, and irritancy testing before release for hospital, pharmacy, or dermatologist distribution.

    Industry compliance standards

    • USP-NF Monographs for topical ingredients
    • FDA 21 CFR Parts 210/211 (CGMP for finished pharmaceuticals)
    • European Pharmacopoeia (EP 10th Ed.)
    • ICH Q3C (Residual Solvents in Pharmaceuticals)

    Typical usage ratio

    • 0.5% – 2.0% by total batch weight, adjusted according to product strength, patient age group, and excipient matrix

    Downstream process integration

    • Dispersion step following primary base melting or liquid blend formation
    • Homogenization before viscosity stabilization and packaging
    • Critical QC checkpoint for uniform distribution

    Final product types

    • Hydrocortisone ointment with antipruritic properties
    • Non-steroidal anti-itch gels
    • Pediatric rash barrier creams
    • Combination antifungal-itch relief topicals

    2. Cosmetic Skin Care Product Formulation

    Cosmetic labs deploy our anti-itch material in skincare designed to calm and moisturize sensitive, atopic, or allergy-prone skin. The ingredient is compatible with a wide variety of oil-in-water and water-in-oil emulsions used in creams, lotions, and aftercare serums. During high-shear emulsification or cold mixing, formulators adjust concentrations to balance itch relief performance with cosmetic safety and user sensory requirements. Production operates under ISO-certified cosmetic GMP systems with full traceability for market release in regions such as the EU, North America, and Asia.

    Industry compliance standards

    • EU Cosmetics Regulation (EC) No. 1223/2009
    • US FDA Voluntary Cosmetic Registration Program (VCRP)
    • Cosmetic Ingredient Review (CIR) Safety Assessments
    • ISO 22716:2007 (Cosmetic GMP)

    Typical usage ratio

    • 0.2% – 1.0%, fine-tuned based on product type, application site, and dermal tolerance

    Downstream process integration

    • Incorporation post-emulsification or at cool-down phase to avoid volatility loss
    • Integrated compatibility assays with co-actives and fragrances
    • Filling and packaging under temperature-controlled conditions

    Final product types

    • Face and body lotions for irritated or sensitive skin
    • After-sun cooling creams
    • Intimate care gels targeting itch
    • Specialized baby care lines

    3. Veterinary Dermatological Product Manufacturing

    Veterinary formulators add our itch relief base to treatments for companion and farm animals experiencing pruritus from allergies, insect bites, or infections. Integration occurs during blending of ointments, sprays, and wipes, ensuring optimum skin coverage and minimized systemic absorption. Labs apply specialized mixing and homogenization protocols for animal health products, aligning with veterinary GMP and regional animal-use regulations. Process validation and analytics ensure batch consistency and species safety for approved veterinary output.

    Industry compliance standards

    • US FDA Center for Veterinary Medicine (CVM) Guidelines
    • VICH GL Quality Guidelines
    • European Medicines Agency (EMA) Veterinary Resolution
    • ANVISA (Brazil) Veterinary Product Regulations

    Typical usage ratio

    • 0.5% – 3.0% tailored by species, animal weight range, and administration route (topical, spray, wipe)

    Downstream process integration

    • Direct blend during base cream preparation or after sterilization for sprays
    • Filter and QC before aseptic or clean fill in animal-use packaging
    • Documented process controls for residue and exposure limits

    Final product types

    • Anti-itch creams and sprays for dogs and cats
    • Insect bite relief wipes for horses
    • Dermatitis management ointments for livestock
    • Medicated animal shampoos

    4. Medicated Personal Hygiene Product Production

    Producers of personal hygiene items utilize this active for items addressing itching caused by chronic skin conditions, dryness, or shaving. The compound is added during manufacture of medicated soaps, feminine care wipes, or anti-itch bath soaks. Quality control systems monitor dose homogeneity, skin compatibility, and preservation when scaling up. Material entry often occurs at the final blending or solution phase to secure performance integrity in finished personal hygiene lines, distributed across pharmacies and retail.

    Industry compliance standards

    • Assessed against FDA OTC Monograph requirements for external analgesics
    • ISO 9001 Quality Management System for hygiene goods
    • CTFA Safety and Labeling Guidelines
    • EU Regulation (EC) No. 1223/2009 for cosmetic hygiene items

    Typical usage ratio

    • 0.3% – 1.5%, adjusted for form (liquid, solid bar, wipe) and consumer use frequency

    Downstream process integration

    • Final-phase addition to avoid high-temperature degradation
    • Integration with surfactants and moisturizers during blending
    • QA sampling for dose uniformity

    Final product types

    • Medicated bath soaks
    • Anti-itch bar soaps and liquid wash
    • Feminine itch relief wipes
    • Moisturizing aftershave gels

    5. Functional Textile and Medical Dressing Finishing

    Industrial users in functional textiles and advanced wound care technology infuse the anti-itch additive through post-weaving finishing or absorption-coating steps. Medical devices and wound dressings integrate the compound to minimize irritation for patients with chronic wounds or post-surgical sensitivities. Factories employ aqueous or solvent-based finishing systems, closely monitoring penetration and residue while adhering to medical-grade materials compliance. QC and regulatory protocols ensure safe, non-leaching final products for use under clinical supervision or in direct contact with skin.

    Industry compliance standards

    • ISO 10993 Biological Evaluation for Medical Devices
    • EN 13795 Medical textiles processing requirements
    • US FDA 510(k) for wound dressings
    • OEKO-TEX Standard 100 for textiles in direct skin contact

    Typical usage ratio

    • 0.2% – 0.8% of total textile or dressing weight, based on liquid uptake tests, leaching stability, and continuous wear duration

    Downstream process integration

    • Application during finishing bath or direct coating pre-drying
    • Immersion or spray treatment synchronised with final QC release
    • Batch validation for surface residue and durability

    Final product types

    • Anti-itch wound contact layers
    • Skin-friendly post-operative dressings
    • Textile-based anti-itch patches
    • Medical-grade antimicrobial gauze

    Free Quote

    Competitive Itch Relief Agent prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing Our Itch Relief Agent – A Practical Solution for Everyday Discomforts

    Our Direct Approach to Skin Comfort

    For years, our team has worked to bridge the gap between chemical expertise and the daily needs of people struggling with persistent itchiness. We don’t just mix compounds in a lab—we listen to feedback from clinics, personal care companies, and field practitioners who see skin irritation every day. Drawing from this experience, we developed the Itch Relief Agent, model IR-2024, to serve those who expect more than a temporary distraction from discomfort.

    As a chemical manufacturer, our commitment starts at the synthesis stage. Every drum, pail, or container shipped from our plant is made with careful attention, because we understand what’s at stake. Methodical processing keeps each batch consistent. We run constant purity checks, not to chase certificates, but to uphold the trust of the people who rely on a steady, high-quality product.

    Why Our Approach to Itch Relief Matters

    From conversations with dermatologists and personal care developers, we realized early on that many products only mask itching for a short while, often relying on menthol or heavy emollients. These temporary fixes often bring cooling or numbing, and in many cases, skin feels dry or sticky afterwards. We sought a different approach—one focused on actually disrupting the chemical signals that cause skin to itch in the first place.

    Our Itch Relief Agent targets histamine pathways. We use a proprietary synthesis technique built around antihistaminic active ingredients, balanced with skin-compatible carriers and stabilizers. Each batch follows a specification for purity and active content, but the real difference comes from the way these compounds act directly at the source of itching—not just the symptoms on the surface.

    For those who endure regular flare-ups from eczema, allergic reactions, or exposure to environmental triggers, this makes a practical difference. We get letters from manufacturers and product formulators describing improved quality-of-life for their end users. Not because the product is flashy or trendy, but because it works reliably where it’s needed.

    What Sets IR-2024 Apart From Ordinary Solutions?

    Compared to basic hydrocortisone or menthol-based products, IR-2024 does not dry out the skin or leave a greasy layer. We achieve this by balancing our base carrier system with both humectant and volatile elements. The active ingredient remains available on the skin for extended hours but doesn’t build up or cause residue, allowing for reapplication whenever irritation flares.

    We made the specification broad enough to suit a range of applications—personal creams, gels, sprays, and wipes—but narrow enough to maintain consistency in action. Many non-prescription solutions overload their formula with fragrances or secondary actives that can aggravate sensitive users. In contrast, we keep fragrances and non-essential additives minimal, letting the core chemistry perform without distraction.

    Usage and Practical Application Feedback

    Clients in skin care, household product, and OTC pharma sectors incorporate our agent into diverse formulations. We design IR-2024 for direct inclusion during blending stages, typically at concentrations depending on the severity and application of the finished product. Some choose rapid-dissolving spray formulas, others opt for slow-release creams. Our technical assistance team, with chemists experienced in emulsion, gel, and surfactant systems, offer real-world guidance for best dispersion and shelf stability. This isn’t a theoretical support desk—these are people who spend hours solving sticky formula problems on production floors.

    The Itch Relief Agent adapts to both water-based gel and oil-based balm formats. We developed specialized grades with enhanced dispersibility for factories working at larger scales. Smaller skin care brands often appreciate our pre-mixed concentrate, which minimizes the learning curve for first-time formulators. Care homes and clinics share positive outcomes from topical applications, reporting fewer complaints of stinging or rebound itch compared with traditional anti-itch actives.

    What We Learned From Our Customers

    Our journey hasn’t been about sitting in an office drafting up spec sheets. The real lessons come from plant managers, shift supervisors, and product designers who aren’t afraid to give direct feedback. We’ve responded to requests for better flowability. We tweaked viscosity ranges—a lesson learned after a messy gel filling run at a major contract manufacturer. We improved packaging integrity after a client’s shipment clumped during a summer heatwave. No lab test replaces the lessons you get facing down a 5,000-liter mixer or pulling samples from a production line under tight deadlines.

    What separates a chemical manufacturer from resellers or traders is the commitment to own every challenge through production cycles. Trading houses can broker deals and move boxes, but they aren’t the ones who answer the call if a batch sets up too fast or clogs an inline filter. Our own plant operators have a strong voice in continuous improvement—most suggestions for process change come straight from production teams, not top management. We know that if a product is tricky for us to produce, it’ll be even harder for our customers to use.

    Our Perspective on Regulations and Consumer Safety

    Over the years, compliance and transparency have become non-negotiable. Every filler, antioxidant, and buffer is chosen with global and local safety standards in mind. We keep full traceability from raw material intake to final drum dispatch. Our safety team reviews all new data from regulatory bodies and medical journals, testing new grades and Actives accordingly. We run stability trials for both northern winters and humid tropics—because product safety doesn’t stop at the factory gate.

    We stay ahead of microcontaminant risks by sourcing from audited and verified suppliers, refusing shortcuts that might compromise batch quality. If a supplier’s raw material falls out of specification, we halt the line and test replacements. Sometimes that means delays, but it’s better than an end user discovering a problem after product launch. We train our technical sales staff in both chemistry and regulatory trends, so when they advise on product design or troubleshooting, their answers hold real weight.

    We also maintain updated documentation for finished goods registration, global export, and compliance audits. All our formulations avoid known carcinogens, persistent organic pollutants, and banned fragrances. In every new project review, we consult toxicologists, dermatologists, and in-house analytical chemists—no shortcuts, no backdoor deals. The world doesn’t stand still, nor do consumer expectations for safety and reliability.

    Challenges We Encounter as a True Manufacturer

    Producing specialized actives like IR-2024 isn’t just chemistry—it’s logistics, labor expertise, and a willingness to confront surprises. We’ve seen raw material prices spike overnight, triggering concern about continuity for long-time customers. There’s no substitute for strategic inventory reserves. Our supply chain team maintains direct relationships with miners, refiners, and intermediary packers, always searching for smarter routes and backup channels. If a key intermediate becomes scarce in one region, we pivot to alternative sources, conduct fresh validation trials, and keep communication clear with our partners.

    Manufacturing at scale also means dealing with unpredictable process upsets. Reactors don’t care about business plans; they respond to temperature swings and mixing rates. Over time, our process engineers built proprietary control recipes, automating the trickier stages to prevent batch-to-batch drift. Operators still double-check hot spots, pH, and reactant additions by hand. This vigilance doesn’t slow us down—it protects our customers from variability that slips through in less disciplined shops.

    Shipping delicate actives across continents poses another challenge. Moisture, vibration, and temperature spikes test every packaging design. We invest in heavy-gauge drums, breathable liners, and fast-acting desiccants. Sometimes, logistics costs rise, but we’d rather eat the extra charge than risk a degraded shipment or a disappointed client. Poor packaging in transit negates all the careful work done in production.

    Earning and Keeping Trust Through Experience

    Our long-term clients understand that trust is earned in hundreds of daily interactions. They visit our site, quiz our operators, tour the lab, and check maintenance logs. We welcome scrutiny because it keeps us honest. This approach sets a direct manufacturer apart from contract fillers or toll blenders, who may not know the details of every input. Our people—from plant floor to analytical lab—carry the whole history of each product in their heads. If an unexpected challenge arises, we solve it together.

    We also champion direct, unfiltered feedback from everyone who uses our product by providing open communication channels. Through these relationships, we keep up with emerging market trends, new clinical evidence, and evolving skin care needs. If a customer points out a recurring irritation from a secondary ingredient, we convene our technical board and, where possible, introduce cleaner variants or hypoallergenic alternatives in the next round of production.

    Unlike distributors or brokers, we can adjust production recipes quickly. If a partner discovers a better dispersion protocol or a new stabilizer, we coordinate pilot batches and share early results. Adjusting to new ideas is what keeps us competitive and allows for tangible improvements year after year.

    Real-World Outcomes: Focus on End Users

    Numbers and certifications tell a story on paper, but the real test of our Itch Relief Agent happens in the field. We supply to companies making everything from mass-market creams to specialized wound care products. Rehabilitation clinics, long-term care facilities, and field medics offer sobering reports. They describe patients who’ve tried multiple over-the-counter creams without relief or who avoid using products due to burning or sticky sensations.

    After field trials, our product met demands for both rapid onset and mildness, without the risk of topical steroid overuse. As one occupational therapist reported, people felt confident using their hands and returning to daily activities without worrying about stains, heaviness, or lingering fragrance.

    For pediatric use, our low-sensitization grade brings peace of mind to parents worried about harsh actives. Feedback from neonatal units indicates better tolerance and almost no secondary stinging, an issue that plagues many other solutions. These outcomes don’t happen by accident—they come from active collaboration, practical field feedback, and relentless process refinement.

    Moving Forward With Itch Relief—A Manufacturer’s Ongoing Mission

    Today’s skin care and personal health markets demand faster innovation and greater responsibility from ingredient manufacturers. With every new batch, we revisit our controls, rethink old assumptions, and talk to the people actually applying our product in real workplaces. Our open-door policy draws on the strengths and experiences of those who know the stakes—production supervisors, clinical users, and front-line nurses.

    The only way to maintain pace is by constant investment in R&D, process automation, and skilled staff. We run side-by-side comparisons of old and new grades, publish our analytical results for partner review, and open our production lines for customer audits. We maintain a culture where improvement ideas are acted upon, not stashed away in a file. Predictability doesn’t mean rigidity—our best innovations have come from surprises during scaled production.

    Customers care about transparency, not just glossy brochures. We walk every buyer through the backstory—the sourcing, the production challenges, the adjustments demanded by real use. As a direct manufacturer, our roots are deep in science, but our focus remains on the everyday problems people face with chronic itch and irritation.

    What to Expect From Us Next

    We are expanding our range to include cleaner-label, plant-sourced variants for companies seeking allergen-free or vegan formulas. Our teams study emerging scientific data on topical anti-itch agents, evaluating promising new actives before they hit the mainstream. If a new molecule passes the test, both in vitro and in daily-use field studies, we gear up for pilot scale and share pre-launch samples. No product leaves our plant without thorough stakeholder evaluation.

    Future developments already center on tailored solutions for immune-compromised users and post-procedure care. Our collaboration with dermatology research clinics ensures our next generation of agents addresses gaps left by old formulas. These partnerships keep us grounded, challenge our assumptions, and lead directly to better products in the hands of real people.

    No Shortcuts—Just Results That Matter

    Manufacturing specialty skin actives means waking up to a new problem nearly every week. Experience teaches us to respect the complexity of chemistry, trust the skill of our teams, and let honest feedback guide development. Our Itch Relief Agent reflects the lessons learned from years spent working shoulder-to-shoulder with customers, not just chasing the next sale.

    For formulators, IR-2024 delivers practical consistency and ease of inclusion, without the baggage that burdens many standard anti-itch compounds. For end users, it brings true relief, minimizing risk of irritation and hassle. Every batch produced tells a story of hands-on refinement, technical debate, and pride in chemical craftsmanship. We don’t promise magic—we make a difference, grounded in the daily grind of real manufacturing.

    Final Thoughts From the Production Floor

    After all the technical processes, compliance updates, and market shifts, our focus never changes: making an itch relief active that brings real comfort, without compromise. We stand behind every kilo of IR-2024, not as faceless suppliers, but as the people who see the impact of reliable solutions every day. From careful sourcing through finished product delivery, we take pride in being part of the solution—not just another link in the supply chain.

    Our door remains open to partners and clients alike. Whether you face an unexpected formulation hiccup or want to work together on next-generation skin actives, our team brings hard-earned insight and practical commitment. The difference between a manufacturer and a middleman is found in every decision, every process tweak, and every follow-up. At the end of the day, the story of our Itch Relief Agent is the story of real people working for lasting results.

    Top